These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections. Madsen PO, Nielsen OS. Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068 [Abstract] [Full Text] [Related]
32. Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema. Schoengut H, Jelinek R. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():219-22. PubMed ID: 6352622 [Abstract] [Full Text] [Related]
35. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Blumer JL, Saiman L, Konstan MW, Melnick D. Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892 [Abstract] [Full Text] [Related]
36. A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection. Gentry LO, Douthit MB, Childs SJ, Madsen PO. J Antimicrob Chemother; 1983 Jul; 12 Suppl A():53-7. PubMed ID: 6352655 [Abstract] [Full Text] [Related]
37. Tobramycin in the treatment of severe and complicated urinary tract infections. Bailey RR, Peddie B. N Z Med J; 1976 Jul 14; 84(567):1-3. PubMed ID: 823477 [Abstract] [Full Text] [Related]
38. Clinical experience with ceftazidime in urology in Japan. Kawamura N. J Antimicrob Chemother; 1983 Jul 14; 12 Suppl A():65-70. PubMed ID: 6352657 [Abstract] [Full Text] [Related]
39. Ceftazidime in the treatment of complicated respiratory and urinary tract infections. Loebis LH, Williams KJ. J Antimicrob Chemother; 1983 Jul 14; 12 Suppl A():59-64. PubMed ID: 6352656 [Abstract] [Full Text] [Related]